Research Progress on the Effects of Obstructive Sleep Apnea on Cardiovascular Disease and Its Treatment
Abstract：Obstructive sleep apnea hypopnea syndrome (OSAHS) is a disease characterized by intermittent hypoxia (IH), autonomic dysfunction, sleep micro-arousals, daytime sleepiness, and fluctuations in thoracic pressure due to the relaxation of upper airway muscles during sleep, leading to repeated collapse of the upper airway and temporary cessation of breathing [1]. The prevalence of OSAHS in developed countries such as Europe and the United States is 9% to 17% among adults, and its incidence in China is at a high level. Mainly due to IH causing physiological changes, leading to increased catecholamine production, increased total peripheral resistance, tachycardia, and increased venous return, resulting in increased cardiac output, hypertension, diabetes, coronary artery disease, and heart failure [2]. A large number of studies have proven that OSAHS is associated with cardiovascular diseases, and this association is independent of risk factors such as obesity, age, and smoking. This article reviews the association between OSAHS and cardiovascular diseases.
Machine-generated Keywords：
Publication Date：2025-07-20
Online Publishing Date：2025-09-09(First online date of this platform, not the publication date of the document)
Pages：3( 884-886 )